| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| D Naber, M Riedel, A Klimke, E-U Vorbach, M Lambert, K-U Kühn, S Bender, B Bandelow, W Lemmer, S Moritz, R W Dittman. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. Acta psychiatrica Scandinavica. vol 111. issue 2. 2005-05-31. PMID:15667429. |
randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia. |
2005-05-31 |
2023-08-12 |
Not clear |
| J-M F Bayard, O S Descamps, S Evrard, J M Dumonceau, L Servais, Z Zingir, S Adams, V Dassy, E Stillemans, A Seutin, P Titeca, J Titec. Case report: acute pancreatitis induced by Clozapine. Acta gastro-enterologica Belgica. vol 68. issue 1. 2005-05-10. PMID:15832593. |
in the present paper, we reported the case of a 39 year-old patient with chronic-hallucinatory schizophrenia who developed symptomatic pancreatitis during the clozapine dose titration performed to reach the therapeutic range. |
2005-05-10 |
2023-08-12 |
Not clear |
| Mary Jo Imbarlina, Sonali Sarkar, Shashi Marwah, Haranath Parepally, Phillip R Johnston, Jaspreet S Brar, K N Roy Chengapp. Leukopenia in clozapine treated patients may be induced by other drugs: a case series. European psychiatry : the journal of the Association of European Psychiatrists. vol 19. issue 8. 2005-05-05. PMID:15589712. |
when adding potentially leukopenic drugs, clinicians should look for possible alternatives especially as clozapine is often a drug used as the last resort in treatment refractory schizophrenia. |
2005-05-05 |
2023-08-12 |
Not clear |
| Lieuwe De Haan, Aygul Oekeneva, Therese Van Amelsvoort, Don Linsze. Obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. European psychiatry : the journal of the Association of European Psychiatrists. vol 19. issue 8. 2005-05-05. PMID:15589719. |
obsessive-compulsive disorder and treatment with clozapine in 200 patients with recent-onset schizophrenia or related disorders. |
2005-05-05 |
2023-08-12 |
Not clear |
| M Monda, An Viggiano, Al Viggiano, F Fuccio, V De Luc. Clozapine blocks sympathetic and thermogenic reactions induced by orexin A in rat. Physiological research. vol 53. issue 5. 2005-04-12. PMID:15479129. |
the same procedure was carried out in rats treated with orexin a plus an intraperitoneal administration of clozapine (8 mg/kg bw), an atypical antipsychotic that is largely used in the therapy of schizophrenia. |
2005-04-12 |
2023-08-12 |
rat |
| Melanie J Dunkley, Michael A Revele. Successful treatment of refractory schizophrenia with combined olanzapine and quetiapine in a patient with a prolactin secreting pituitary microadenoma. Journal of psychopharmacology (Oxford, England). vol 19. issue 1. 2005-04-12. PMID:15671135. |
treatment-resistant schizophrenia presents a particular problem in patients who, for whatever reason, cannot be treated with clozapine. |
2005-04-12 |
2023-08-12 |
Not clear |
| Melanie J Dunkley, Michael A Revele. Successful treatment of refractory schizophrenia with combined olanzapine and quetiapine in a patient with a prolactin secreting pituitary microadenoma. Journal of psychopharmacology (Oxford, England). vol 19. issue 1. 2005-04-12. PMID:15671135. |
we present a patient with treatment resistant schizophrenia and a prolactin-secreting microadenoma of the pituitary who was intolerant of clozapine therapy. |
2005-04-12 |
2023-08-12 |
Not clear |
| Brian Cook, Gerry Hoogenboo. Combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. vol 12. issue 1. 2005-04-11. PMID:15715745. |
combined use of amisulpride and clozapine for patients with treatment-resistant schizophrenia. |
2005-04-11 |
2023-08-12 |
Not clear |
| Bruce L Lambert, Ken-Yu Chang, Eskinder Tafesse, William Carso. Association between antipsychotic treatment and hyperlipidemia among California Medicaid patients with schizophrenia. Journal of clinical psychopharmacology. vol 25. issue 1. 2005-04-08. PMID:15643095. |
to examine the risk of hyperlipidemia among people with schizophrenia exposed to new antipsychotics (clozapine, olanzapine, quetiapine, risperidone) compared with those exposed to older generation antipsychotics. |
2005-04-08 |
2023-08-12 |
Not clear |
| M Seshaman. Is clozapine cost-effective? Unanswered issues. The European journal of health economics : HEPAC : health economics in prevention and care. vol 3 Suppl 2. 2005-04-04. PMID:15609156. |
this review examines six key cost-effectiveness studies that address the economic considerations and quality-of-life issues associated with the use of clozapine in battling the burdens of schizophrenia to determine whether in fact the use of clozapine is clinically and economically appropriate. |
2005-04-04 |
2023-08-12 |
Not clear |
| K H Kho, B A Blansjaar, S de Vries, D Babuskova, A H Zwinderman, D H Linsze. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study. European archives of psychiatry and clinical neuroscience. vol 254. issue 6. 2005-03-29. PMID:15538604. |
electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study. |
2005-03-29 |
2023-08-12 |
Not clear |
| K H Kho, B A Blansjaar, S de Vries, D Babuskova, A H Zwinderman, D H Linsze. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study. European archives of psychiatry and clinical neuroscience. vol 254. issue 6. 2005-03-29. PMID:15538604. |
this open label study describes the efficacy of electroconvulsive therapy (ect) as adjunctive treatment in clozapine nonresponders suffering from schizophrenia. |
2005-03-29 |
2023-08-12 |
Not clear |
| Nitsan Kozlovsky, Carmit Nadri, Galila Aga. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 15. issue 1. 2005-03-29. PMID:15572268. |
chronic treatment of rats with lithium, valproate, haloperidol or clozapine did not change rat cortical gsk-3beta protein levels ex vivo, supporting the concept that low gsk-3beta in schizophrenia is not secondary to stress or drug treatment. |
2005-03-29 |
2023-08-12 |
rat |
| Chih-Ya Cheng, Chen-Jee Hong, Shih-Jen Tsa. Effects of subchronic clozapine administration on serum glucose, cholesterol and triglyceride levels, and body weight in male BALB/c mice. Life sciences. vol 76. issue 19. 2005-03-28. PMID:15733941. |
atypical antipsychotics, like clozapine, have fewer extrapyramidal side effects compared with typical antipsychotics, however, such treatment is associated with several adverse metabolic effects such as weight gain, hyperglycemia and hyperlipidemia in patients with schizophrenia. |
2005-03-28 |
2023-08-12 |
mouse |
| Tomiki Sumiyoshi, A Roy, C-H Kim, K Jayathilake, M A Lee, C Sumiyoshi, H Y Meltze. Prediction of changes in memory performance by plasma homovanillic acid levels in clozapine-treated patients with schizophrenia. Psychopharmacology. vol 177. issue 1-2. 2005-03-23. PMID:15179543. |
clozapine has been found to improve some domains of cognition, including verbal memory, in patients with schizophrenia. |
2005-03-23 |
2023-08-12 |
Not clear |
| P M Llorca, J J Per. [Leponex, 10 years after -- a clinical review]. L'Encephale. vol 30. issue 5. 2005-03-22. PMID:15627052. |
clozapine was one of the major advances in the treatment of schizophrenia since the introduction of the classic antipsychotic agent chlorpromazine in the 1950s. |
2005-03-22 |
2023-08-12 |
Not clear |
| P M Llorca, J J Per. [Leponex, 10 years after -- a clinical review]. L'Encephale. vol 30. issue 5. 2005-03-22. PMID:15627052. |
this provides the opportunity to update the data on clozapine in the treatment of schizophrenia. |
2005-03-22 |
2023-08-12 |
Not clear |
| P M Llorca, J J Per. [Leponex, 10 years after -- a clinical review]. L'Encephale. vol 30. issue 5. 2005-03-22. PMID:15627052. |
in this article we review current clinical evidence in schizophrenia to address the following issues: 1) efficacy in refractory/positive symptoms: a systematic and critical analysis of 14 double-blind clinical trials in comparison with both standard and novel antipsychotics show consistent findings in favour of clozapine, with all but three of the reports demonstrating superiority. |
2005-03-22 |
2023-08-12 |
Not clear |
| P M Llorca, J J Per. [Leponex, 10 years after -- a clinical review]. L'Encephale. vol 30. issue 5. 2005-03-22. PMID:15627052. |
finally, the place of clozapine in the current treatment of schizophrenia is highlighted to inform the development of guidelines for clinical management. |
2005-03-22 |
2023-08-12 |
Not clear |
| R Alexander Bantick, Andrew J Montgomery, Christopher J Bench, Tariq Choudhry, Nina Malek, Peter J McKenna, Digby J Quested, J F William Deakin, Paul M Grasb. A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment. Journal of psychopharmacology (Oxford, England). vol 18. issue 3. 2005-03-17. PMID:15358978. |
a positron emission tomography study of the 5-ht1a receptor in schizophrenia and during clozapine treatment. |
2005-03-17 |
2023-08-12 |
human |